Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Structure Therapeutics
Biotech
Structure patches up shares after GLP-1 linked to 6% weight loss
After investors frowned on Structure’s oral GLP-1 data in 2023, the biotech is back with a new cut showing 6% weight loss in a phase 2a study.
Annalee Armstrong
Jun 3, 2024 10:17am
Xaira, Anthos, CureVac & more—Chutes & Ladders
Apr 26, 2024 8:30am
Structure tumbles as oral GLP-1 data underwhelm investors
Dec 18, 2023 10:04am
Structure posts early oral obesity data, delays larger readout
Sep 29, 2023 7:30am
Few biotechs dare to test 'eerie' Wall Street IPO market
May 8, 2023 6:00am